Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25;16(2):e0247718.
doi: 10.1371/journal.pone.0247718. eCollection 2021.

Effect of a high crude protein content diet during energy restriction and re-alimentation on animal performance, skeletal growth and metabolism of bone tissue in two genotypes of cattle

Affiliations

Effect of a high crude protein content diet during energy restriction and re-alimentation on animal performance, skeletal growth and metabolism of bone tissue in two genotypes of cattle

Tiago A C C Silva et al. PLoS One. .

Abstract

The objective of this study was to investigate the effect of diet crude protein (CP) content and metabolisable energy (ME) intake on skeletal growth and associated parameters of growing steers prior to and during compensatory growth in weight and catch-up growth in skeletal elongation. The experiment was a factorial design with two cattle genotypes [Brahman crossbred (BX, 178 ± 6 kg) and Holstein-Friesian (HF, 230 ± 34 kg)] and three nutritional treatments; high CP content and high ME intake (HCP-HME), high CP content and low ME intake (HCP-LME) and low CP content and low ME intake (LCP-LME) with the ME intake of HCP-LME matched to that of LCP-LME. Nutritional treatments were imposed over a 103 d period (Phase 1), and after this, all steers were offered ad libitum access to the HCP-HME nutritional treatment for 100 d (Phase 2). Steers fed the high CP content treatment with a low ME intake, showed higher hip height gain (P = 0.04), larger terminal hypertrophic chondrocytes (P = 0.02) and a higher concentration of total triiodothyronine in plasma (P = 0.01) than steers with the same ME intake of the low CP content treatment. In addition, the low CP treatment resulted in significant decreases in bone volume (P = 0.03), bone surface area (P = 0.03) and the concentration of bone-specific alkaline phosphatase in plasma (P < 0.001) compared to steers fed the HCP-HME treatment. A significant interaction between genotype and nutritional treatment existed for the concentration of thyroxine (T4) in plasma where HF steers fed LCP-LME had a lower T4 concentration in plasma (P = 0.05) than BX steers. All steers with a restricted ME intake during Phase 1 demonstrated compensatory growth during Phase 2. However, HF steers fed the LCP treatment during Phase 1 showed a tendency (P = 0.07) for a greater LWG during Phase 2 without any increase in dry matter intake. Results observed at the growth plate and hip height growth suggest that catch-up growth in cattle may also be explained by the growth plate senescence hypothesis. Contrary to our initial hypothesis, the results demonstrate that greater CP intake during ME restriction does not increase compensatory gain in cattle during re-alimentation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Mason trichrome stained sections of cattle’s growth plate and trabecular of tuber coxae bone and photographed at 1X (a) and 4X (b) objectives. Histomorphometric assessments were conducted at the trabecular bone (a) as well as at the proliferative and hypertrophic zones of the growth plate (b).
Fig 2
Fig 2
Dry matter (DM) intake and liveweight gain of Holstein-Friesian (a and b) and Brahman crossbred (c and d) steers fed high crude protein and high metabolizable energy content (HCP-HME), high CP and low ME content (HCP-LME) and low CP and low ME content (LCP-LME) diets throughout the experiment. The different nutritional treatments were imposed from day 1 until day 103 (Phase 1), after that all steers were fed HCP-HME ad libitum until day 203 (Phase 2). Dashed grey line represents the transition from Phase 1 to Phase 2. Error bars represents standard error of the mean.
Fig 3
Fig 3. Effect of metabolizable energy (ME) intake (MEI) on liveweight gain (LWG; a; Y = -0.507 +5.95X, R2 = 0.92, RSE = 0.16, P < 0.001) and crude protein (CP) intake (CPI) on hip height gain (HHG; b; Y = 16.41 + 13.75X, R2 = 0.82, RSE = 13, P < 0.001) of steers fed high CP content and high ME intake (HCP-HME), high CP content and low ME intake (HCP-LME) and low CP content and low ME intake (LCP-LME).
Each symbol represents the mean for an individual steer from Phase 1 and Phase 2 of the experiment.
Fig 4
Fig 4. Change in trabecular bone volume (Bv/Tv) of tuber coxae samples collected from Holstein-Friesian (HF) and Brahman crossbred (BX) steers fed different nutritional treatments (Phase 1; a) and during re-alimentation (Phase 2; b).
During Phase 1, the interaction between genotype and nutritional factors was not significant so the means of both genotypes were pooled by nutritional treatment. Data are expressed as mean ± SEM. Means with different letters are significantly different (Tukey, P < 0.05).

Similar articles

Cited by

References

    1. Coutinho EL, Gomes ARS, França CN, Oishi J, Salvini TF. Effect of passive stretching on the immobilized soleus muscle fiber morphology. Brazilian Journal of Medical and Biological Research. 2004;37:1853–1861. 10.1590/s0100-879x2004001200011 - DOI - PubMed
    1. Williams PE, Goldspink G. The effect of immobilization on the longitudinal growth of striated muscle fibres. Journal of Anatomy. 1973;116(Pt 1):45–55. PMC1271549. - PMC - PubMed
    1. Young M, Sykes A. Bone growth and muscularity. Proceedings of the New Zealand Society of Animal Production 1987, Vol. 47: 73–75.
    1. Huxley JS, Teissier G. Terminology of relative growth. Nature. 1936;137(3471):780–781.
    1. Ashworth A. Growth rates in children recovering from protein-calorie malnutrition. British journal of nutrition. 1969;23(04):835–845. 10.1079/bjn19690094 - DOI - PubMed

Publication types

Substances